ARTELO Story

<div class='circular--portrait' style='background:#006400;color: #FFE4E1;font-size:4em;'>AB</div>
ARTL -- USA Stock  

USD 1.14  0.13  12.87%

ARTELO BIOSCIENCES Current Ratio is relatively stable at the moment as compared to the past year. The company's current value of Current Ratio is estimated at 4.96. Debt to Equity Ratio is expected to hike to 0.16 this year, although the value of Earnings before Tax will most likely fall to (4.3 M). One of the important factors of profitable assets selection is to know the future growth potential of an asset before buying its shares. This post will summarize ARTELO BIOSCIENCES. We will analyze why it could be a much better year for ARTELO BIOSCIENCES shareholders. ARTELO BIOSCIENCES INC probability of distress is under 43 percent. Will ARTELO BIOSCIENCES stakeholders continue to pick up in February?
Published over a week ago
View all stories for ARTELO BIOSCIENCES | View All Stories
Does ARTELO BIOSCIENCES (NASDAQ:ARTL) have steady essential indicators based on the new hike?
ARTELO BIOSCIENCES appears to be abnormally volatile, given 1 month investment horizon. ARTELO BIOSCIENCES INC secures Sharpe Ratio (or Efficiency) of 0.0906, which signifies that the company had 0.0906% of return per unit of risk over the last month. Our philosophy in foreseeing the volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. By analyzing ARTELO BIOSCIENCES INC technical indicators you can now evaluate if the expected return of 0.54% is justified by implied risk. Please makes use of ARTELO BIOSCIENCES INC risk adjusted performance of 0.0568, and Mean Deviation of 4.63 to double-check if our risk estimates are consistent with your expectations.
Typically, a company's financial statements are the reports that show the financial position of the company. There are three main documents that fall into the category of financial statements. These documents include ARTELO BIOSCIENCES income statement, its balance sheet, and the statement of cash flows. Potential ARTELO BIOSCIENCES investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although ARTELO BIOSCIENCES investors may use each financial statement separately, they are all related. The changes in ARTELO BIOSCIENCES's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ARTELO BIOSCIENCES's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages. The goal of ARTELO BIOSCIENCES fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of ARTELO BIOSCIENCES performance into the future periods or doing a reasonable stock valuation. The intrinsic value of ARTELO BIOSCIENCES shares is the value that is considered the true value of the share. If the intrinsic value ARTELO is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares ARTELO BIOSCIENCES. Please read more on our fundamental analysis page.

Watch out for price decline

Please consider monitoring ARTELO BIOSCIENCES on a daily basis if you are holding a position in it. ARTELO BIOSCIENCES is trading at a penny-stock level, and the possibility of delisting is much higher compared to other equities. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion. Most exchanges require public instruments, such as ARTELO BIOSCIENCES stock to be traded above the $1 level to remain listed. If ARTELO BIOSCIENCES stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.

How important is ARTELO BIOSCIENCES's Liquidity

ARTELO BIOSCIENCES financial leverage refers to using borrowed capital as a funding source to finance ARTELO BIOSCIENCES INC ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. ARTELO BIOSCIENCES financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between ARTELO BIOSCIENCES's total debt and its cash.

How ARTELO utilizes its cash?

To perform a cash flow analysis of ARTELO BIOSCIENCES, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash ARTELO BIOSCIENCES is receiving and how much cash it distributes out in a given period. The ARTELO BIOSCIENCES cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. ARTELO BIOSCIENCES Net Cash Flow from Operations is relatively stable at the moment as compared to the past year. The company's current value of Net Cash Flow from Operations is estimated at (4.02 Million)

An Additional Perspective On ARTELO BIOSCIENCES INC

The company reported the previous year's revenue of 212.82 M. Net Loss for the year was (4.65 M) with profit before overhead, payroll, taxes, and interest of 83.01 M.

Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ARTELO BIOSCIENCES has an asset utilization ratio of 138.85 percent. This denotes that the company is making $1.39 for each dollar of assets. An increasing asset utilization means that ARTELO BIOSCIENCES INC is more efficient with each dollar of assets it utilizes for everyday operations.

Current Assets
2.9 M
Assets Non Current
M
Goodwill
1.8 M
Current Assets2.9 Million42.98
Assets Non Current2.02 Million29.97
Goodwill1.82 Million27.05

Is ARTELO BIOSCIENCES pull down permanent?

New Information Ratio is up to 0.02. Price may pull down again. ARTELO BIOSCIENCES INC exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate ARTELO BIOSCIENCES INC individually to make sure intended market timing strategies and available technical indicagtors are consistent with their estimates about ARTELO BIOSCIENCES future systematic risk. ARTELO BIOSCIENCES INC is a potential penny stock. Although ARTELO BIOSCIENCES may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in ARTELO BIOSCIENCES INC. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

While other companies in the biotechnology industry are either recovering or due for a correction, ARTELO BIOSCIENCES may not be performing as strong as the other in terms of long-term growth potentials. With a less-than optimistic outlook for your 30 days horizon, it may be a good time to drop some or all of your ARTELO BIOSCIENCES holdings as it seems the potential growth was already fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to ARTELO BIOSCIENCES.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of ARTELO BIOSCIENCES INC. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com